scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1053-2498(02)00557-0 |
P8608 | Fatcat ID | release_hf5fltucmjeqff5ylgbgfqpeai |
P698 | PubMed publication ID | 12873541 |
P50 | author | Leanne E Felkin | Q47232644 |
Paul J Barton | Q51099950 | ||
P2093 | author name string | Magdi H Yacoub | |
Emma J Birks | |||
Martin E Cullen | |||
Maren U Koban | |||
P2860 | cites work | Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase | Q28291219 |
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells | Q28581437 | ||
Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy | Q30479528 | ||
A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery | Q33938975 | ||
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction | Q37526800 | ||
JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells | Q43597895 | ||
Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices | Q43727871 | ||
A novel method for real time quantitative RT-PCR. | Q46544663 | ||
Improved Left Ventricular Function After Chronic Left Ventricular Unloading | Q57635931 | ||
Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter | Q58211802 | ||
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) | Q59192167 | ||
A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure | Q59599298 | ||
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy | Q71021087 | ||
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy | Q71616014 | ||
Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice | Q73396260 | ||
Serum cytokines in left ventricular assist device candidates | Q73669774 | ||
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro | Q73919594 | ||
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy | Q74561892 | ||
Differential expression of tissue inhibitors of metalloproteinases in the failing human heart | Q77465345 | ||
TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling | Q77763464 | ||
Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function | Q78151176 | ||
P433 | issue | 7 | |
P921 | main subject | heart failure | Q181754 |
P304 | page(s) | 738-744 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
P1476 | title | Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. | |
P478 | volume | 22 |
Q38313155 | A modified Glenn shunt reduces venous congestion during acute right ventricular failure due to pulmonary banding: a randomized experimental study |
Q38249997 | Biomarkers in mechanical circulatory support |
Q37688051 | Cardiac fibrosis in mouse expressing DsRed tetramers involves chronic autophagy and proteasome degradation insufficiency. |
Q38521958 | Cardiac transcriptional response to acute and chronic angiotensin II treatments |
Q35582221 | Changes in the myocardial interstitium and contribution to the progression of heart failure |
Q33789760 | Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy. |
Q46731184 | Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes |
Q92988695 | Education and Lifestyle Factors Are Associated with DNA Methylation Clocks in Older African Americans |
Q38632188 | Extracellular matrix-mediated cellular communication in the heart. |
Q51887932 | Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies. |
Q42712058 | Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies |
Q34266734 | Inhalant nitrite exposure alters mouse hepatic angiogenic gene expression |
Q88726712 | Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload |
Q38121745 | Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases |
Q37959015 | Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know |
Q55333525 | Relationship of polymorphisms in the tissue inhibitor of metalloproteinase (TIMP)-1 and -2 genes with chronic heart failure. |
Q37258938 | Serial gene expression profiling in the intact human heart |
Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
Q28076570 | The fibrosis-cell death axis in heart failure |
Q51021947 | The role of the cardiac Na+/Ca2+ exchanger in reverse remodeling: relevance for LVAD-recovery. |
Q37895982 | Tissue inhibitor of metalloproteinases (TIMPs) in heart failure |
Q54373723 | Unloading the infarcted heart affect MMPs-TIMPs axis in a rat cardiac heterotopic transplantation model. |
Q33791183 | Use of biomarkers of collagen types I and III fibrosis metabolism to detect cardiovascular and renal disease in chimpanzees (Pan troglodytes) |
Search more.